Eli Lilly Reaches $1 Trillion Market Value

Eli Lilly, a pharmaceutical giant, recently achieved a one trillion dollar market value, joining tech titans like Nvidia and Amazon. Their success is driven by the rising popularity of GLP-one weight-loss treatments, such as Zepbound and Mounjaro, which are gaining traction among U.S. adults. The companys stock has surged by over thirty-six percent this year, with a fifty-four percent increase in revenue to seventeen point six billion dollars due to strong sales of weight loss and diabetes medications. A survey shows that thirteen percent of U.S. adults are currently using these weight-loss drugs, with one in five adults having used them before and another one in five interested in trying. A new agreement with the Trump administration in November opened up new markets for Eli Lilly, and their dominance in the weight-loss industry is expected to continue with an upcoming weight-loss pill.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.